PRELUDE CAPITAL MANAGEMENT, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$577,104
-35.5%
28,042
+47.5%
0.04%
-37.3%
Q2 2023$894,179
+52.2%
19,017
+35.8%
0.06%
+68.6%
Q1 2023$587,440
+28.1%
14,000
+16.5%
0.04%
+45.8%
Q4 2022$458,519
-53.4%
12,022
-52.1%
0.02%
-31.4%
Q3 2022$983,000
+21.8%
25,106
+0.5%
0.04%
+52.2%
Q2 2022$807,000
+143.8%
24,973
+149.8%
0.02%
+130.0%
Q1 2022$331,000
+21.2%
9,997
+107.8%
0.01%
+25.0%
Q2 2021$273,000
-58.3%
4,812
-36.5%
0.01%
-52.9%
Q4 2020$655,000
+87.7%
7,574
+32.7%
0.02%0.0%
Q3 2020$349,000
-1.4%
5,708
-32.9%
0.02%
-10.5%
Q2 2020$354,000
-73.3%
8,502
-53.7%
0.02%
-62.0%
Q4 2019$1,327,000
-39.0%
18,381
+18.5%
0.05%
-49.0%
Q3 2019$2,176,000
-8.5%
15,511
+19.4%
0.10%
-16.2%
Q2 2019$2,379,000
+825.7%
12,992
+614.6%
0.12%
+680.0%
Q3 2018$257,000
-46.1%
1,818
-40.4%
0.02%
-50.0%
Q2 2018$477,000
-2.9%
3,049
-0.1%
0.03%
-16.7%
Q1 2018$491,000
-21.9%
3,051
-20.1%
0.04%
-29.4%
Q4 2017$629,000
+159.9%
3,820
-1.5%
0.05%
+131.8%
Q3 2017$242,000
-40.0%
3,880
-23.3%
0.02%
-42.1%
Q2 2017$403,000
+11.9%
5,0600.0%0.04%
+11.8%
Q1 2017$360,000
+44.0%
5,060
+3.2%
0.03%
+13.3%
Q4 2016$250,0004,9010.03%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders